UK tribunal correctly analyzed ‘clear-cut’ drug pricing case, CMA says
By Simon Zekaria ( June 25, 2026, 15:42 GMT | Insight) -- The UK's Competition Appeal Tribunal correctly analyzed an antitrust infringement case that targeted a clutch of drugmakers over their commercial practices in supplying hydrocortisone tablets, the Competition and Markets Authority told appeal judges on Thursday. The CMA rejects accusations from companies including Auden Mckenzie that the CAT had made errors of law in upholding findings from the watchdog.The UK competition tribunal correctly analyzed an antitrust infringement case that targeted a clutch of drugmakers over their commercial practices in supplying hydrocortisone tablets, the competition regulator told appeal judges on Thursday....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.